vs

Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and STARZ ENTERTAINMENT CORP (STRZ). Click either name above to swap in a different company.

STARZ ENTERTAINMENT CORP is the larger business by last-quarter revenue ($320.9M vs $168.4M, roughly 1.9× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -7.5%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -40.6%).

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

Starz Entertainment Corp., formerly known as Lions Gate Entertainment Corporation, or simply Lionsgate, is a Canadian-American entertainment company currently headquartered in Santa Monica, California. Founded by Frank Giustra on July 10, 1997, it is/was domiciled and incorporated in Vancouver, British Columbia.

ESPR vs STRZ — Head-to-Head

Bigger by revenue
STRZ
STRZ
1.9× larger
STRZ
$320.9M
$168.4M
ESPR
Growing faster (revenue YoY)
ESPR
ESPR
+151.2% gap
ESPR
143.7%
-7.5%
STRZ
Faster 2-yr revenue CAGR
ESPR
ESPR
Annualised
ESPR
10.6%
-40.6%
STRZ

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ESPR
ESPR
STRZ
STRZ
Revenue
$168.4M
$320.9M
Net Profit
$-52.6M
Gross Margin
Operating Margin
50.6%
-10.8%
Net Margin
-16.4%
Revenue YoY
143.7%
-7.5%
Net Profit YoY
-71.9%
EPS (diluted)
$0.32
$-3.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESPR
ESPR
STRZ
STRZ
Q4 25
$168.4M
Q3 25
$87.3M
$320.9M
Q2 25
$82.4M
$319.7M
Q1 25
$65.0M
Q4 24
$69.1M
$970.5M
Q3 24
$51.6M
$346.9M
Q2 24
$73.8M
$347.6M
Q1 24
$137.7M
Net Profit
ESPR
ESPR
STRZ
STRZ
Q4 25
Q3 25
$-31.3M
$-52.6M
Q2 25
$-12.7M
$-42.5M
Q1 25
$-40.5M
Q4 24
$-21.9M
Q3 24
$-29.5M
$-30.6M
Q2 24
$-61.9M
$4.2M
Q1 24
$61.0M
Operating Margin
ESPR
ESPR
STRZ
STRZ
Q4 25
50.6%
Q3 25
-11.4%
-10.8%
Q2 25
8.6%
-8.4%
Q1 25
-34.0%
Q4 24
-6.4%
3.7%
Q3 24
-31.0%
-4.9%
Q2 24
3.5%
2.9%
Q1 24
52.5%
Net Margin
ESPR
ESPR
STRZ
STRZ
Q4 25
Q3 25
-35.9%
-16.4%
Q2 25
-15.4%
-13.3%
Q1 25
-62.2%
Q4 24
-2.3%
Q3 24
-57.2%
-8.8%
Q2 24
-83.9%
1.2%
Q1 24
44.3%
EPS (diluted)
ESPR
ESPR
STRZ
STRZ
Q4 25
$0.32
Q3 25
$-0.16
$-3.15
Q2 25
$-0.06
$-2.54
Q1 25
$-0.21
Q4 24
$-0.14
$-0.09
Q3 24
$-0.15
$-1.83
Q2 24
$-0.33
$0.26
Q1 24
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESPR
ESPR
STRZ
STRZ
Cash + ST InvestmentsLiquidity on hand
$167.9M
$37.0M
Total DebtLower is stronger
$608.7M
Stockholders' EquityBook value
$-302.0M
$663.2M
Total Assets
$465.9M
$2.0B
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESPR
ESPR
STRZ
STRZ
Q4 25
$167.9M
Q3 25
$92.4M
$37.0M
Q2 25
$86.1M
$51.6M
Q1 25
$114.6M
Q4 24
$144.8M
$200.5M
Q3 24
$144.7M
$229.6M
Q2 24
$189.3M
$192.5M
Q1 24
$226.6M
Total Debt
ESPR
ESPR
STRZ
STRZ
Q4 25
Q3 25
$608.7M
Q2 25
$611.7M
Q1 25
Q4 24
$2.4B
Q3 24
$2.1B
Q2 24
$1.5B
Q1 24
Stockholders' Equity
ESPR
ESPR
STRZ
STRZ
Q4 25
$-302.0M
Q3 25
$-451.4M
$663.2M
Q2 25
$-433.5M
$712.3M
Q1 25
$-426.2M
Q4 24
$-388.7M
$-168.3M
Q3 24
$-370.2M
$935.9M
Q2 24
$-344.2M
$973.1M
Q1 24
$-294.3M
Total Assets
ESPR
ESPR
STRZ
STRZ
Q4 25
$465.9M
Q3 25
$364.0M
$2.0B
Q2 25
$347.1M
$2.1B
Q1 25
$324.0M
Q4 24
$343.8M
$7.2B
Q3 24
$314.1M
$7.1B
Q2 24
$352.3M
$7.2B
Q1 24
$373.1M
Debt / Equity
ESPR
ESPR
STRZ
STRZ
Q4 25
Q3 25
0.92×
Q2 25
0.86×
Q1 25
Q4 24
Q3 24
2.24×
Q2 24
1.59×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESPR
ESPR
STRZ
STRZ
Operating Cash FlowLast quarter
$45.2M
$-26.1M
Free Cash FlowOCF − Capex
$-31.3M
FCF MarginFCF / Revenue
-9.8%
Capex IntensityCapex / Revenue
0.0%
1.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-317.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESPR
ESPR
STRZ
STRZ
Q4 25
$45.2M
Q3 25
$-4.3M
$-26.1M
Q2 25
$-31.4M
$65.4M
Q1 25
$-22.6M
Q4 24
$-35.0M
$-335.3M
Q3 24
$-35.3M
$9.1M
Q2 24
$-7.2M
$-33.5M
Q1 24
$53.8M
Free Cash Flow
ESPR
ESPR
STRZ
STRZ
Q4 25
Q3 25
$-31.3M
Q2 25
$58.5M
Q1 25
Q4 24
$-349.3M
Q3 24
$-35.5M
$4.4M
Q2 24
$-7.3M
$-38.4M
Q1 24
$53.8M
FCF Margin
ESPR
ESPR
STRZ
STRZ
Q4 25
Q3 25
-9.8%
Q2 25
18.3%
Q1 25
Q4 24
-36.0%
Q3 24
-68.7%
1.3%
Q2 24
-9.9%
-11.0%
Q1 24
39.0%
Capex Intensity
ESPR
ESPR
STRZ
STRZ
Q4 25
0.0%
Q3 25
0.0%
1.6%
Q2 25
0.0%
2.2%
Q1 25
0.0%
Q4 24
0.0%
1.4%
Q3 24
0.3%
1.4%
Q2 24
0.1%
1.4%
Q1 24
0.1%
Cash Conversion
ESPR
ESPR
STRZ
STRZ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-7.98×
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESPR
ESPR

Collaboration Revenue$124.7M74%
Products$43.7M26%

STRZ
STRZ

Over The Top Subscription Service OTT$222.8M69%
Linear Subscription Service$98.1M31%

Related Comparisons